Correlation Between Guyoung Technology and Prestige Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Guyoung Technology and Prestige Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Guyoung Technology and Prestige Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Guyoung Technology Co and Prestige Biologics Co, you can compare the effects of market volatilities on Guyoung Technology and Prestige Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Guyoung Technology with a short position of Prestige Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Guyoung Technology and Prestige Biologics.

Diversification Opportunities for Guyoung Technology and Prestige Biologics

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between Guyoung and Prestige is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Guyoung Technology Co and Prestige Biologics Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prestige Biologics and Guyoung Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Guyoung Technology Co are associated (or correlated) with Prestige Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prestige Biologics has no effect on the direction of Guyoung Technology i.e., Guyoung Technology and Prestige Biologics go up and down completely randomly.

Pair Corralation between Guyoung Technology and Prestige Biologics

Assuming the 90 days trading horizon Guyoung Technology Co is expected to generate 0.5 times more return on investment than Prestige Biologics. However, Guyoung Technology Co is 2.0 times less risky than Prestige Biologics. It trades about -0.12 of its potential returns per unit of risk. Prestige Biologics Co is currently generating about -0.12 per unit of risk. If you would invest  235,500  in Guyoung Technology Co on September 22, 2024 and sell it today you would lose (36,400) from holding Guyoung Technology Co or give up 15.46% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy98.41%
ValuesDaily Returns

Guyoung Technology Co  vs.  Prestige Biologics Co

 Performance 
       Timeline  
Guyoung Technology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Guyoung Technology Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Prestige Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Prestige Biologics Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Guyoung Technology and Prestige Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Guyoung Technology and Prestige Biologics

The main advantage of trading using opposite Guyoung Technology and Prestige Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Guyoung Technology position performs unexpectedly, Prestige Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prestige Biologics will offset losses from the drop in Prestige Biologics' long position.
The idea behind Guyoung Technology Co and Prestige Biologics Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets